data_1hfh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hfh _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.35 0.119 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -21.49 137.04 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 O-C-N 126.26 2.225 . . . . 0.0 112.976 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.7 mp -86.76 139.93 33.22 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -67.49 164.07 32.34 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.05 1.833 . . . . 0.0 108.211 170.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.504 ' HB3' ' NE1' ' A' ' 55' ' ' TRP . 11.3 m -101.43 176.12 5.35 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.87 -83.194 98.359 100.863 103.889 2.018 104.474 90.684 165.462 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.3 p -119.25 -169.5 1.76 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.443 ' NE2' ' HA ' ' A' ' 24' ' ' GLU . 75.1 mm-40 -33.93 111.64 0.39 Allowed Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 125.022 1.451 . . . . 0.0 109.816 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.553 ' HD3' ' CE1' ' A' ' 26' ' ' TYR . 18.5 Cg_endo -46.65 163.16 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 122.589 2.193 . . . . 0.0 112.082 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.588 ' HD3' ' CG ' ' A' ' 55' ' ' TRP . 93.1 Cg_endo -73.8 -173.08 1.25 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 N-CA-C 105.852 -2.403 . . . . 0.0 105.852 -169.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -127.55 150.6 49.62 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.568 HD13 ' SG ' ' A' ' 36' ' ' CYS . 10.8 mt -91.58 152.41 3.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 1 N-CA-C 97.778 -4.897 . . . . 0.0 97.778 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.453 ' CG ' ' NE2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -22.95 -46.2 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -141.85 42.17 1.7 Allowed 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 112.108 -2.314 . . . . 0.0 113.34 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.32 177.64 20.93 Favored Glycine 0 N--CA 1.504 3.181 0 O-C-N 121.905 -0.497 . . . . 0.0 113.008 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 170.86 15.27 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 8' ' ' PRO . 4.3 tp -77.98 146.31 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.303 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -120.46 62.23 0.86 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 122.8 1.286 . . . . 0.0 107.598 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.7 t -121.9 95.42 4.65 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.8 p 35.78 66.41 0.35 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.886 1.366 . . . . 0.0 110.925 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 21.41 -96.1 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 111.78 -2.464 . . . . 0.0 113.691 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -124.55 94.59 4.24 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.8 p -121.16 -53.83 2.02 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.542 -1.663 . . . . 0.0 108.472 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -116.54 166.62 11.89 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 113.604 -1.635 . . . . 0.0 111.036 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.443 ' HA ' ' NE2' ' A' ' 7' ' ' GLN . 6.9 mm-40 -115.52 -42.52 3.13 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.3 p -111.17 155.86 22.27 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 113.649 -1.614 . . . . 0.0 108.106 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.553 ' CE1' ' HD3' ' A' ' 8' ' ' PRO . 66.7 m-85 -126.5 168.11 14.7 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 113.523 -1.671 . . . . 0.0 106.742 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.77 -177.98 5.13 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.722 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -90.02 135.42 33.66 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.86 -2.644 . . . . 0.0 103.86 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.17 34.93 16.18 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 103.568 -3.813 . . . . 0.0 103.568 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 26' ' ' TYR . 26.2 m -108.73 123.21 48.65 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 48' ' ' THR . 4.5 ptpt -120.31 114.5 21.95 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.727 -2.033 . . . . 0.0 108.045 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.415 HD13 ' CD2' ' A' ' 26' ' ' TYR . 43.5 mt -105.11 165.88 10.78 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 112.427 -2.169 . . . . 0.0 106.932 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.5 m -98.05 168.88 10.0 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.486 ' CD1' HD12 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -127.36 164.43 21.83 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 118.194 -1.403 . . . . 0.0 113.158 -179.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.7 m -150.08 148.16 28.67 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.808 -1.996 . . . . 0.0 109.034 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.568 ' SG ' HD13 ' A' ' 11' ' ' ILE . 46.4 m -125.4 167.71 14.58 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.234 179.41 -76.784 125.051 82.297 106.527 2.017 98.827 155.067 -54.824 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -37.11 157.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.4 120.2 20.96 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.441 ' C ' HD22 ' A' ' 64' ' ' LEU . . . 120.35 -70.75 0.36 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -24.28 140.13 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -110.2 140.38 44.38 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 102.83 -3.026 . . . . 0.0 102.83 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.8 tt -110.77 128.66 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 124.199 0.937 . . . . 0.0 110.772 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.9 p -115.88 158.22 23.3 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.633 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 60.74 86.05 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 112.812 -1.994 . . . . 0.0 107.221 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 15.64 113.17 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 126.347 2.279 . . . . 0.0 114.934 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -68.48 74.72 0.26 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -150.02 149.96 31.09 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.611 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 6.0 t -130.57 161.51 31.38 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.2 m -132.53 156.39 46.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 124.405 1.066 . . . . 0.0 108.214 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.2 t -116.12 130.97 57.05 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 124.708 1.255 . . . . 0.0 110.932 -179.976 165.462 90.684 100.863 104.474 2.018 103.889 98.359 -83.194 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -133.45 134.31 43.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 125.04 1.462 . . . . 0.0 107.427 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 10.6 mtp 40.97 31.49 0.13 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.94 -6.76 83.41 Favored Glycine 0 N--CA 1.507 3.378 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -103.98 146.51 28.58 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.588 ' CG ' ' HD3' ' A' ' 9' ' ' PRO . 82.6 m95 -103.85 160.67 14.6 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.6 m -94.15 166.74 11.97 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.0 t -62.23 131.28 93.56 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.525 ' CB ' HG12 ' A' ' 11' ' ' ILE . 49.4 Cg_endo -53.63 -179.77 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.873 2.382 . . . . 0.0 114.064 173.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 58' ' ' PRO . 40.2 Cg_endo -53.04 -179.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 123.434 2.756 . . . . 0.0 112.417 162.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -114.59 100.4 8.25 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.784 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.5 m -98.52 145.98 26.24 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 179.194 -54.824 155.067 82.297 98.827 2.017 106.527 125.051 -76.784 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 169.71 -162.16 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.512 ' HA2' ' CZ ' ' A' ' 86' ' ' TYR . . . 102.15 -15.97 55.97 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.441 HD22 ' C ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -80.7 137.95 50.83 Favored Pre-proline 0 N--CA 1.481 1.077 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -54.51 131.17 44.0 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 122.306 2.004 . . . . 0.0 111.688 165.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -99.51 177.33 5.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.539 -99.162 -143.009 -109.398 96.968 2.018 108.248 -112.315 -136.355 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -98.25 -173.36 2.55 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.69 178.28 2.1 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 102.903 -2.999 . . . . 0.0 102.903 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -64.44 155.65 64.9 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 N-CA-C 108.969 -1.204 . . . . 0.0 108.969 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.404 ' HD3' ' CD1' ' A' ' 113' ' ' TRP . 40.4 Cg_endo -74.0 172.57 15.67 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 123.403 2.736 . . . . 0.0 106.611 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -105.11 162.65 13.2 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.4 pt -125.0 176.64 5.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 113.973 -1.467 . . . . 0.0 114.923 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.1 p -89.29 -35.42 16.14 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 112.974 -1.921 . . . . 0.0 115.203 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.413 ' CB ' ' O ' ' A' ' 119' ' ' CYS . 6.9 m170 -116.84 -8.64 11.32 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.9 -159.05 9.46 Favored Glycine 0 N--CA 1.501 2.994 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.1 p -173.54 132.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.697 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.54 ' HB ' ' CG ' ' A' ' 92' ' ' TYR . 8.8 p -100.68 121.69 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.06 -16.2 14.87 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 110.787 -2.915 . . . . 0.0 107.512 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -112.85 61.11 0.64 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.425 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.402 ' SD ' HG12 ' A' ' 77' ' ' VAL . 9.2 ptt? -114.76 151.99 32.82 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 111.796 -2.456 . . . . 0.0 105.584 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.4 m -95.77 -170.02 2.06 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.96 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -110.35 -39.18 5.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 125.018 1.449 . . . . 0.0 108.927 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.9 p -109.68 77.29 1.05 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -97.48 115.54 27.99 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.27 125.59 51.35 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.59 ' HB3' ' HA2' ' A' ' 110' ' ' GLY . 19.3 p90 -8.94 145.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 121.658 3.947 . . . . 0.0 121.658 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.6 36.61 83.61 Favored Glycine 0 N--CA 1.492 2.418 0 CA-C-N 113.167 -1.833 . . . . 0.0 112.688 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -125.36 161.94 25.9 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -126.9 156.45 41.42 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.543 HG23 ' CZ3' ' A' ' 113' ' ' TRP . 17.9 m -133.63 161.42 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 112.415 -2.175 . . . . 0.0 108.218 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.67 123.98 36.84 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 125.538 1.774 . . . . 0.0 110.444 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.564 ' CG ' ' HG2' ' A' ' 117' ' ' PRO . 0.1 OUTLIER -99.99 -179.19 4.08 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -117.5 176.49 5.14 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.1 m -103.84 174.31 5.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 124.294 0.996 . . . . 0.0 109.86 -179.994 -65.09 -32.641 -66.14 103.01 2.016 103.272 -93.684 -53.466 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.74 -170.74 1.73 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -103.5 130.74 50.94 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 98.51 6.83 56.31 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -107.76 165.2 11.62 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.08 175.15 15.66 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 105.124 -3.191 . . . . 0.0 105.124 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.0 mt -117.2 150.59 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 118.64 -1.224 . . . . 0.0 112.199 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 102' ' ' GLY . 18.4 t70 -112.59 -135.69 0.36 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 112.386 -2.188 . . . . 0.0 107.449 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.535 ' H ' ' CG ' ' A' ' 101' ' ' ASP . . . -91.36 -91.75 1.36 Allowed Glycine 0 N--CA 1.5 2.924 0 CA-C-O 117.537 -1.702 . . . . 0.0 113.004 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -85.81 132.18 4.01 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 CA-C-N 120.595 2.198 . . . . 0.0 113.427 -172.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.421 ' HA ' ' H ' ' A' ' 118' ' ' SER . . . -96.88 35.72 1.51 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.2 pt -120.78 177.2 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.218 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -138.69 135.5 34.86 Favored 'General case' 0 C--N 1.301 -1.528 1 N-CA-C 98.286 -4.709 . . . . 0.0 98.286 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 114' ' ' SER . 33.6 tttm -119.59 124.47 46.43 Favored 'General case' 0 N--CA 1.514 2.748 0 CA-C-N 119.564 1.074 . . . . 0.0 110.207 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -78.08 145.94 35.51 Favored 'General case' 0 N--CA 1.504 2.272 0 C-N-CA 118.758 -1.177 . . . . 0.0 113.912 -179.228 -136.355 -112.315 -109.398 108.248 2.018 96.968 -143.009 -99.162 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.437 ' O ' ' CE1' ' A' ' 13' ' ' HIS . 0.3 OUTLIER -130.4 74.98 1.62 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 111.612 -2.54 . . . . 0.0 109.903 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 86' ' ' TYR . . . 66.52 -37.6 0.17 Allowed Glycine 0 N--CA 1.511 3.685 0 N-CA-C 116.574 1.389 . . . . 0.0 116.574 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -124.65 -69.82 0.78 Allowed 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 119.425 1.612 . . . . 0.0 111.658 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HG2' ' H ' ' A' ' 113' ' ' TRP . 17.6 ttpt -105.2 -163.1 0.92 Allowed 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.543 ' CZ3' HG23 ' A' ' 90' ' ' VAL . 41.1 m95 -115.3 175.94 5.29 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.425 ' HB2' HD12 ' A' ' 109' ' ' LEU . 7.5 t -117.57 -179.0 3.6 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.446 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -0.67 77.37 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 126.808 2.567 . . . . 0.0 114.812 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -66.58 161.86 39.53 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.601 1.534 . . . . 0.0 108.881 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.564 ' HG2' ' CG ' ' A' ' 92' ' ' TYR . 0.1 OUTLIER -25.39 158.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 N-CA-C 122.293 3.92 . . . . 0.0 122.293 -173.388 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.421 ' H ' ' HA ' ' A' ' 104' ' ' ALA . 18.7 m -110.85 61.48 0.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 111.124 -2.762 . . . . 0.0 112.275 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 74' ' ' HIS . 55.0 m -135.48 76.65 1.63 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 179.763 -53.466 -93.684 -66.14 103.272 2.016 103.01 -32.641 -65.09 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.483 ' H ' ' CD1' ' A' ' 120' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.513 2.696 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.35 0.119 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.432 ' HD2' ' CD2' ' A' ' 28' ' ' HIS . 66.6 mttm -21.49 137.04 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 O-C-N 126.26 2.225 . . . . 0.0 112.976 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 3' ' ' ILE . 4.7 mp -86.76 139.93 33.22 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.404 ' O ' HG22 ' A' ' 3' ' ' ILE . 94.7 Cg_endo -67.49 164.07 32.34 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.05 1.833 . . . . 0.0 108.211 170.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.525 ' HB3' ' NE1' ' A' ' 55' ' ' TRP . 11.3 m -101.43 176.12 5.35 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.87 -83.194 98.359 100.863 103.889 2.018 104.474 90.684 165.462 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.3 p -119.25 -169.5 1.76 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.439 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 24.4 mm100 -33.93 111.64 0.39 Allowed Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 125.022 1.451 . . . . 0.0 109.816 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.619 ' HD3' ' CE1' ' A' ' 26' ' ' TYR . 18.5 Cg_endo -46.65 163.16 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 122.589 2.193 . . . . 0.0 112.082 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.628 ' HD3' ' CG ' ' A' ' 55' ' ' TRP . 93.1 Cg_endo -73.8 -173.08 1.25 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 N-CA-C 105.852 -2.403 . . . . 0.0 105.852 -169.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -127.55 150.6 49.62 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.67 HD12 ' SG ' ' A' ' 36' ' ' CYS . 10.8 mt -91.58 152.41 3.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 1 N-CA-C 97.778 -4.897 . . . . 0.0 97.778 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -22.95 -46.2 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -141.85 42.17 1.7 Allowed 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 112.108 -2.314 . . . . 0.0 113.34 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.32 177.64 20.93 Favored Glycine 0 N--CA 1.504 3.181 0 O-C-N 121.905 -0.497 . . . . 0.0 113.008 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 170.86 15.27 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 8' ' ' PRO . 4.3 tp -77.98 146.31 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.303 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -120.46 62.23 0.86 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 122.8 1.286 . . . . 0.0 107.598 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.7 t -121.9 95.42 4.65 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.8 p 35.78 66.41 0.35 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.886 1.366 . . . . 0.0 110.925 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 21.41 -96.1 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 111.78 -2.464 . . . . 0.0 113.691 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -124.55 94.59 4.24 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.8 p -121.16 -53.83 2.02 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.542 -1.663 . . . . 0.0 108.472 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -116.54 166.62 11.89 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 113.604 -1.635 . . . . 0.0 111.036 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -115.52 -42.52 3.13 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.3 p -111.17 155.86 22.27 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 113.649 -1.614 . . . . 0.0 108.106 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.619 ' CE1' ' HD3' ' A' ' 8' ' ' PRO . 66.7 m-85 -126.5 168.11 14.7 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 113.523 -1.671 . . . . 0.0 106.742 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.77 -177.98 5.13 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.722 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.432 ' CD2' ' HD2' ' A' ' 2' ' ' LYS . 21.1 p-80 -90.02 135.42 33.66 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.86 -2.644 . . . . 0.0 103.86 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.17 34.93 16.18 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 103.568 -3.813 . . . . 0.0 103.568 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 26' ' ' TYR . 26.2 m -108.73 123.21 48.65 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 48' ' ' THR . 4.5 ptpt -120.31 114.5 21.95 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.727 -2.033 . . . . 0.0 108.045 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.488 ' HB2' HD11 ' A' ' 16' ' ' ILE . 43.5 mt -105.11 165.88 10.78 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 112.427 -2.169 . . . . 0.0 106.932 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.5 m -98.05 168.88 10.0 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.549 ' CD1' HD11 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -127.36 164.43 21.83 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 118.194 -1.403 . . . . 0.0 113.158 -179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.7 m -150.08 148.16 28.67 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.808 -1.996 . . . . 0.0 109.034 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.67 ' SG ' HD12 ' A' ' 11' ' ' ILE . 46.4 m -125.4 167.71 14.58 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.234 179.41 -76.784 125.051 82.297 106.527 2.017 98.827 155.067 -54.824 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -37.11 157.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.4 120.2 20.96 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.442 ' C ' HD21 ' A' ' 64' ' ' LEU . . . 120.35 -70.75 0.36 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.566 ' CZ ' ' HA3' ' A' ' 110' ' ' GLY . 4.4 m-85 -24.28 140.13 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -110.2 140.38 44.38 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 102.83 -3.026 . . . . 0.0 102.83 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.443 HD13 ' HB3' ' A' ' 46' ' ' ASN . 11.8 tt -110.77 128.66 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 124.199 0.937 . . . . 0.0 110.772 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.9 p -115.88 158.22 23.3 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.633 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 60.74 86.05 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 112.812 -1.994 . . . . 0.0 107.221 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 15.64 113.17 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 126.347 2.279 . . . . 0.0 114.934 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.443 ' HB3' HD13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -68.48 74.72 0.26 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -150.02 149.96 31.09 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.611 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 6.0 t -130.57 161.51 31.38 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.2 m -132.53 156.39 46.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 124.405 1.066 . . . . 0.0 108.214 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.2 t -116.12 130.97 57.05 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 124.708 1.255 . . . . 0.0 110.932 -179.976 165.462 90.684 100.863 104.474 2.018 103.889 98.359 -83.194 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -133.45 134.31 43.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 125.04 1.462 . . . . 0.0 107.427 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 10.6 mtp 40.97 31.49 0.13 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.94 -6.76 83.41 Favored Glycine 0 N--CA 1.507 3.378 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -103.98 146.51 28.58 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.628 ' CG ' ' HD3' ' A' ' 9' ' ' PRO . 82.6 m95 -103.85 160.67 14.6 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.6 m -94.15 166.74 11.97 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.412 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 47.0 t -62.23 131.28 93.56 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.55 ' CB ' HG12 ' A' ' 11' ' ' ILE . 49.4 Cg_endo -53.63 -179.77 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.873 2.382 . . . . 0.0 114.064 173.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.421 ' HD2' ' CB ' ' A' ' 58' ' ' PRO . 40.2 Cg_endo -53.04 -179.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 123.434 2.756 . . . . 0.0 112.417 162.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -114.59 100.4 8.25 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.784 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.5 m -98.52 145.98 26.24 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 179.194 -54.824 155.067 82.297 98.827 2.017 106.527 125.051 -76.784 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 169.71 -162.16 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.525 ' HA2' ' CZ ' ' A' ' 86' ' ' TYR . . . 102.15 -15.97 55.97 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.488 ' HA ' ' HD2' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -80.7 137.95 50.83 Favored Pre-proline 0 N--CA 1.481 1.077 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.488 ' HD2' ' HA ' ' A' ' 64' ' ' LEU . 46.5 Cg_endo -54.51 131.17 44.0 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 122.306 2.004 . . . . 0.0 111.688 165.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -99.51 177.33 5.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.539 -99.162 -143.009 -109.398 96.968 2.018 108.248 -112.315 -136.355 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -98.25 -173.36 2.55 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.69 178.28 2.1 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 102.903 -2.999 . . . . 0.0 102.903 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -64.44 155.65 64.9 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 N-CA-C 108.969 -1.204 . . . . 0.0 108.969 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HD3' ' CD1' ' A' ' 113' ' ' TRP . 40.4 Cg_endo -74.0 172.57 15.67 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 123.403 2.736 . . . . 0.0 106.611 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -105.11 162.65 13.2 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.4 pt -125.0 176.64 5.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 113.973 -1.467 . . . . 0.0 114.923 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.1 p -89.29 -35.42 16.14 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 112.974 -1.921 . . . . 0.0 115.203 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.413 ' CB ' ' O ' ' A' ' 119' ' ' CYS . 6.9 m170 -116.84 -8.64 11.32 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.9 -159.05 9.46 Favored Glycine 0 N--CA 1.501 2.994 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.1 p -173.54 132.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.697 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.64 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 8.8 p -100.68 121.69 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.06 -16.2 14.87 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 110.787 -2.915 . . . . 0.0 107.512 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -112.85 61.11 0.64 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.425 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.416 ' SD ' HG13 ' A' ' 77' ' ' VAL . 9.2 ptt? -114.76 151.99 32.82 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 111.796 -2.456 . . . . 0.0 105.584 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.4 m -95.77 -170.02 2.06 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.96 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -110.35 -39.18 5.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 125.018 1.449 . . . . 0.0 108.927 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.9 p -109.68 77.29 1.05 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -97.48 115.54 27.99 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.27 125.59 51.35 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.753 ' HB3' ' HA2' ' A' ' 110' ' ' GLY . 19.3 p90 -8.94 145.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 121.658 3.947 . . . . 0.0 121.658 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.6 36.61 83.61 Favored Glycine 0 N--CA 1.492 2.418 0 CA-C-N 113.167 -1.833 . . . . 0.0 112.688 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -125.36 161.94 25.9 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -126.9 156.45 41.42 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.558 HG22 ' CZ3' ' A' ' 113' ' ' TRP . 17.9 m -133.63 161.42 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 112.415 -2.175 . . . . 0.0 108.218 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.422 HG23 HG22 ' A' ' 105' ' ' ILE . 0.0 OUTLIER -127.67 123.98 36.84 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 125.538 1.774 . . . . 0.0 110.444 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.653 ' CG ' ' HG2' ' A' ' 117' ' ' PRO . 0.1 OUTLIER -99.99 -179.19 4.08 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -117.5 176.49 5.14 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.1 m -103.84 174.31 5.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 124.294 0.996 . . . . 0.0 109.86 -179.994 -65.09 -32.641 -66.14 103.01 2.016 103.272 -93.684 -53.466 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.74 -170.74 1.73 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -103.5 130.74 50.94 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 98.51 6.83 56.31 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -107.76 165.2 11.62 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.08 175.15 15.66 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 105.124 -3.191 . . . . 0.0 105.124 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 118' ' ' SER . 11.0 mt -117.2 150.59 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 118.64 -1.224 . . . . 0.0 112.199 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 102' ' ' GLY . 18.4 t70 -112.59 -135.69 0.36 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 112.386 -2.188 . . . . 0.0 107.449 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.506 ' H ' ' CG ' ' A' ' 101' ' ' ASP . . . -91.36 -91.75 1.36 Allowed Glycine 0 N--CA 1.5 2.924 0 CA-C-O 117.537 -1.702 . . . . 0.0 113.004 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -85.81 132.18 4.01 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 CA-C-N 120.595 2.198 . . . . 0.0 113.427 -172.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.426 ' HA ' ' H ' ' A' ' 118' ' ' SER . . . -96.88 35.72 1.51 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.422 HG22 HG23 ' A' ' 91' ' ' THR . 3.2 pt -120.78 177.2 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.218 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -138.69 135.5 34.86 Favored 'General case' 0 C--N 1.301 -1.528 1 N-CA-C 98.286 -4.709 . . . . 0.0 98.286 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 114' ' ' SER . 33.6 tttm -119.59 124.47 46.43 Favored 'General case' 0 N--CA 1.514 2.748 0 CA-C-N 119.564 1.074 . . . . 0.0 110.207 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -78.08 145.94 35.51 Favored 'General case' 0 N--CA 1.504 2.272 0 C-N-CA 118.758 -1.177 . . . . 0.0 113.912 -179.228 -136.355 -112.315 -109.398 108.248 2.018 96.968 -143.009 -99.162 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' A' ' 114' ' ' SER . 0.3 OUTLIER -130.4 74.98 1.62 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 111.612 -2.54 . . . . 0.0 109.903 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.753 ' HA2' ' HB3' ' A' ' 86' ' ' TYR . . . 66.52 -37.6 0.17 Allowed Glycine 0 N--CA 1.511 3.685 0 N-CA-C 116.574 1.389 . . . . 0.0 116.574 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -124.65 -69.82 0.78 Allowed 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 119.425 1.612 . . . . 0.0 111.658 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.566 ' HG2' ' H ' ' A' ' 113' ' ' TRP . 17.6 ttpt -105.2 -163.1 0.92 Allowed 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 41.1 m95 -115.3 175.94 5.29 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.509 ' HB2' HD11 ' A' ' 109' ' ' LEU . 7.5 t -117.57 -179.0 3.6 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.446 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -0.67 77.37 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 126.808 2.567 . . . . 0.0 114.812 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -66.58 161.86 39.53 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.601 1.534 . . . . 0.0 108.881 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.653 ' HG2' ' CG ' ' A' ' 92' ' ' TYR . 0.1 OUTLIER -25.39 158.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 N-CA-C 122.293 3.92 . . . . 0.0 122.293 -173.388 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 100' ' ' ILE . 18.7 m -110.85 61.48 0.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 111.124 -2.762 . . . . 0.0 112.275 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 74' ' ' HIS . 55.0 m -135.48 76.65 1.63 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 179.763 -53.466 -93.684 -66.14 103.272 2.016 103.01 -32.641 -65.09 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.644 HD13 ' H ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.513 2.696 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.35 0.119 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.432 ' HD2' ' CD2' ' A' ' 28' ' ' HIS . 66.6 mttm -21.49 137.04 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 O-C-N 126.26 2.225 . . . . 0.0 112.976 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 3' ' ' ILE . 4.7 mp -86.76 139.93 33.22 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.404 ' O ' HG22 ' A' ' 3' ' ' ILE . 94.7 Cg_endo -67.49 164.07 32.34 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.05 1.833 . . . . 0.0 108.211 170.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.525 ' HB3' ' NE1' ' A' ' 55' ' ' TRP . 11.3 m -101.43 176.12 5.35 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.87 -83.194 98.359 100.863 103.889 2.018 104.474 90.684 165.462 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.3 p -119.25 -169.5 1.76 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.476 HE21 ' HA ' ' A' ' 24' ' ' GLU . 75.1 mm-40 -33.93 111.64 0.39 Allowed Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 125.022 1.451 . . . . 0.0 109.816 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.619 ' HD3' ' CE1' ' A' ' 26' ' ' TYR . 18.5 Cg_endo -46.65 163.16 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 122.589 2.193 . . . . 0.0 112.082 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.628 ' HD3' ' CG ' ' A' ' 55' ' ' TRP . 93.1 Cg_endo -73.8 -173.08 1.25 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 N-CA-C 105.852 -2.403 . . . . 0.0 105.852 -169.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -127.55 150.6 49.62 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.67 HD12 ' SG ' ' A' ' 36' ' ' CYS . 10.8 mt -91.58 152.41 3.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 1 N-CA-C 97.778 -4.897 . . . . 0.0 97.778 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -22.95 -46.2 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -141.85 42.17 1.7 Allowed 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 112.108 -2.314 . . . . 0.0 113.34 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.32 177.64 20.93 Favored Glycine 0 N--CA 1.504 3.181 0 O-C-N 121.905 -0.497 . . . . 0.0 113.008 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 170.86 15.27 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 8' ' ' PRO . 4.3 tp -77.98 146.31 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.303 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -120.46 62.23 0.86 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 122.8 1.286 . . . . 0.0 107.598 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.7 t -121.9 95.42 4.65 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.8 p 35.78 66.41 0.35 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.886 1.366 . . . . 0.0 110.925 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 21.41 -96.1 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 111.78 -2.464 . . . . 0.0 113.691 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -124.55 94.59 4.24 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.8 p -121.16 -53.83 2.02 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.542 -1.663 . . . . 0.0 108.472 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -116.54 166.62 11.89 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 113.604 -1.635 . . . . 0.0 111.036 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HA ' HE21 ' A' ' 7' ' ' GLN . 6.9 mm-40 -115.52 -42.52 3.13 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.3 p -111.17 155.86 22.27 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 113.649 -1.614 . . . . 0.0 108.106 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.619 ' CE1' ' HD3' ' A' ' 8' ' ' PRO . 66.7 m-85 -126.5 168.11 14.7 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 113.523 -1.671 . . . . 0.0 106.742 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.77 -177.98 5.13 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.722 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.432 ' CD2' ' HD2' ' A' ' 2' ' ' LYS . 21.1 p-80 -90.02 135.42 33.66 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.86 -2.644 . . . . 0.0 103.86 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.17 34.93 16.18 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 103.568 -3.813 . . . . 0.0 103.568 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 26' ' ' TYR . 26.2 m -108.73 123.21 48.65 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 48' ' ' THR . 4.5 ptpt -120.31 114.5 21.95 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.727 -2.033 . . . . 0.0 108.045 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.488 ' HB2' HD11 ' A' ' 16' ' ' ILE . 43.5 mt -105.11 165.88 10.78 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 112.427 -2.169 . . . . 0.0 106.932 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.5 m -98.05 168.88 10.0 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.549 ' CD1' HD11 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -127.36 164.43 21.83 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 118.194 -1.403 . . . . 0.0 113.158 -179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.7 m -150.08 148.16 28.67 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.808 -1.996 . . . . 0.0 109.034 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.67 ' SG ' HD12 ' A' ' 11' ' ' ILE . 46.4 m -125.4 167.71 14.58 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.234 179.41 -76.784 125.051 82.297 106.527 2.017 98.827 155.067 -54.824 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -37.11 157.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.4 120.2 20.96 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.442 ' C ' HD21 ' A' ' 64' ' ' LEU . . . 120.35 -70.75 0.36 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.566 ' CZ ' ' HA3' ' A' ' 110' ' ' GLY . 4.4 m-85 -24.28 140.13 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -110.2 140.38 44.38 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 102.83 -3.026 . . . . 0.0 102.83 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.443 HD13 ' HB3' ' A' ' 46' ' ' ASN . 11.8 tt -110.77 128.66 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 124.199 0.937 . . . . 0.0 110.772 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.9 p -115.88 158.22 23.3 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.633 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 60.74 86.05 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 112.812 -1.994 . . . . 0.0 107.221 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 15.64 113.17 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 126.347 2.279 . . . . 0.0 114.934 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.443 ' HB3' HD13 ' A' ' 42' ' ' ILE . 20.9 p30 -68.48 74.72 0.26 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -150.02 149.96 31.09 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.611 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 6.0 t -130.57 161.51 31.38 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.2 m -132.53 156.39 46.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 124.405 1.066 . . . . 0.0 108.214 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.2 t -116.12 130.97 57.05 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 124.708 1.255 . . . . 0.0 110.932 -179.976 165.462 90.684 100.863 104.474 2.018 103.889 98.359 -83.194 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -133.45 134.31 43.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 125.04 1.462 . . . . 0.0 107.427 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 10.6 mtp 40.97 31.49 0.13 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.94 -6.76 83.41 Favored Glycine 0 N--CA 1.507 3.378 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -103.98 146.51 28.58 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.628 ' CG ' ' HD3' ' A' ' 9' ' ' PRO . 82.6 m95 -103.85 160.67 14.6 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.6 m -94.15 166.74 11.97 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.412 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 47.0 t -62.23 131.28 93.56 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.55 ' CB ' HG12 ' A' ' 11' ' ' ILE . 49.4 Cg_endo -53.63 -179.77 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.873 2.382 . . . . 0.0 114.064 173.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.421 ' HD2' ' CB ' ' A' ' 58' ' ' PRO . 40.2 Cg_endo -53.04 -179.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 123.434 2.756 . . . . 0.0 112.417 162.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -114.59 100.4 8.25 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.784 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.5 m -98.52 145.98 26.24 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 179.194 -54.824 155.067 82.297 98.827 2.017 106.527 125.051 -76.784 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 169.71 -162.16 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.525 ' HA2' ' CZ ' ' A' ' 86' ' ' TYR . . . 102.15 -15.97 55.97 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.488 ' HA ' ' HD2' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -80.7 137.95 50.83 Favored Pre-proline 0 N--CA 1.481 1.077 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.488 ' HD2' ' HA ' ' A' ' 64' ' ' LEU . 46.5 Cg_endo -54.51 131.17 44.0 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 122.306 2.004 . . . . 0.0 111.688 165.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -99.51 177.33 5.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.539 -99.162 -143.009 -109.398 96.968 2.018 108.248 -112.315 -136.355 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -98.25 -173.36 2.55 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.69 178.28 2.1 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 102.903 -2.999 . . . . 0.0 102.903 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -64.44 155.65 64.9 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 N-CA-C 108.969 -1.204 . . . . 0.0 108.969 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HD3' ' CD1' ' A' ' 113' ' ' TRP . 40.4 Cg_endo -74.0 172.57 15.67 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 123.403 2.736 . . . . 0.0 106.611 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -105.11 162.65 13.2 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.4 pt -125.0 176.64 5.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 113.973 -1.467 . . . . 0.0 114.923 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.1 p -89.29 -35.42 16.14 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 112.974 -1.921 . . . . 0.0 115.203 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.413 ' CB ' ' O ' ' A' ' 119' ' ' CYS . 6.9 m170 -116.84 -8.64 11.32 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.9 -159.05 9.46 Favored Glycine 0 N--CA 1.501 2.994 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.1 p -173.54 132.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.697 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.64 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 8.8 p -100.68 121.69 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.06 -16.2 14.87 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 110.787 -2.915 . . . . 0.0 107.512 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -112.85 61.11 0.64 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.425 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.416 ' SD ' HG13 ' A' ' 77' ' ' VAL . 9.2 ptt? -114.76 151.99 32.82 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 111.796 -2.456 . . . . 0.0 105.584 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.4 m -95.77 -170.02 2.06 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.96 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -110.35 -39.18 5.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 125.018 1.449 . . . . 0.0 108.927 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.9 p -109.68 77.29 1.05 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -97.48 115.54 27.99 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.27 125.59 51.35 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.753 ' HB3' ' HA2' ' A' ' 110' ' ' GLY . 19.3 p90 -8.94 145.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 121.658 3.947 . . . . 0.0 121.658 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.6 36.61 83.61 Favored Glycine 0 N--CA 1.492 2.418 0 CA-C-N 113.167 -1.833 . . . . 0.0 112.688 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -125.36 161.94 25.9 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -126.9 156.45 41.42 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.558 HG22 ' CZ3' ' A' ' 113' ' ' TRP . 17.9 m -133.63 161.42 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 112.415 -2.175 . . . . 0.0 108.218 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.422 HG23 HG22 ' A' ' 105' ' ' ILE . 0.0 OUTLIER -127.67 123.98 36.84 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 125.538 1.774 . . . . 0.0 110.444 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.653 ' CG ' ' HG2' ' A' ' 117' ' ' PRO . 0.1 OUTLIER -99.99 -179.19 4.08 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -117.5 176.49 5.14 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.1 m -103.84 174.31 5.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 124.294 0.996 . . . . 0.0 109.86 -179.994 -65.09 -32.641 -66.14 103.01 2.016 103.272 -93.684 -53.466 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.74 -170.74 1.73 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -103.5 130.74 50.94 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 98.51 6.83 56.31 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -107.76 165.2 11.62 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.08 175.15 15.66 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 105.124 -3.191 . . . . 0.0 105.124 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 118' ' ' SER . 11.0 mt -117.2 150.59 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 118.64 -1.224 . . . . 0.0 112.199 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 102' ' ' GLY . 18.4 t70 -112.59 -135.69 0.36 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 112.386 -2.188 . . . . 0.0 107.449 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.506 ' H ' ' CG ' ' A' ' 101' ' ' ASP . . . -91.36 -91.75 1.36 Allowed Glycine 0 N--CA 1.5 2.924 0 CA-C-O 117.537 -1.702 . . . . 0.0 113.004 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -85.81 132.18 4.01 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 CA-C-N 120.595 2.198 . . . . 0.0 113.427 -172.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.426 ' HA ' ' H ' ' A' ' 118' ' ' SER . . . -96.88 35.72 1.51 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.422 HG22 HG23 ' A' ' 91' ' ' THR . 3.2 pt -120.78 177.2 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.218 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -138.69 135.5 34.86 Favored 'General case' 0 C--N 1.301 -1.528 1 N-CA-C 98.286 -4.709 . . . . 0.0 98.286 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 114' ' ' SER . 33.6 tttm -119.59 124.47 46.43 Favored 'General case' 0 N--CA 1.514 2.748 0 CA-C-N 119.564 1.074 . . . . 0.0 110.207 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -78.08 145.94 35.51 Favored 'General case' 0 N--CA 1.504 2.272 0 C-N-CA 118.758 -1.177 . . . . 0.0 113.912 -179.228 -136.355 -112.315 -109.398 108.248 2.018 96.968 -143.009 -99.162 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' A' ' 114' ' ' SER . 0.3 OUTLIER -130.4 74.98 1.62 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 111.612 -2.54 . . . . 0.0 109.903 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.753 ' HA2' ' HB3' ' A' ' 86' ' ' TYR . . . 66.52 -37.6 0.17 Allowed Glycine 0 N--CA 1.511 3.685 0 N-CA-C 116.574 1.389 . . . . 0.0 116.574 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -124.65 -69.82 0.78 Allowed 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 119.425 1.612 . . . . 0.0 111.658 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.566 ' HG2' ' H ' ' A' ' 113' ' ' TRP . 17.6 ttpt -105.2 -163.1 0.92 Allowed 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 41.1 m95 -115.3 175.94 5.29 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.509 ' HB2' HD11 ' A' ' 109' ' ' LEU . 7.5 t -117.57 -179.0 3.6 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.446 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -0.67 77.37 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 126.808 2.567 . . . . 0.0 114.812 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -66.58 161.86 39.53 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.601 1.534 . . . . 0.0 108.881 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.653 ' HG2' ' CG ' ' A' ' 92' ' ' TYR . 0.1 OUTLIER -25.39 158.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 N-CA-C 122.293 3.92 . . . . 0.0 122.293 -173.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 100' ' ' ILE . 18.7 m -110.85 61.48 0.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 111.124 -2.762 . . . . 0.0 112.275 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 74' ' ' HIS . 55.0 m -135.48 76.65 1.63 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 179.763 -53.466 -93.684 -66.14 103.272 2.016 103.01 -32.641 -65.09 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.644 HD13 ' H ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.513 2.696 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -178.874 . . . . . . . . 2 2 . 1 stop_ save_